Cargando…

Emodin Protects Against Lipopolysaccharide-Induced Acute Lung Injury via the JNK/Nur77/c-Jun Signaling Pathway

Background: Acute lung injury (ALI) is a serious inflammatory disease with clinical manifestations of hypoxemia and respiratory failure. Presently, there is no effective treatment of ALI. Although emodin from Rheum palmatum L. exerts anti-ALI properties, the underlying mechanisms have not been fully...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Pei, Yan, Li-Jun, Zhou, Hong-Ling, Cao, Hui-Hui, Zheng, Yuan-Ru, Lu, Zi-Bin, Yang, Hua-Yi, Ma, Jia-Mei, Chen, Yu-Yao, Huo, Chuying, Tian, Chunyang, Liu, Jun-Shan, Yu, Lin-Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968870/
https://www.ncbi.nlm.nih.gov/pubmed/35370650
http://dx.doi.org/10.3389/fphar.2022.717271
_version_ 1784679135775293440
author Xie, Pei
Yan, Li-Jun
Zhou, Hong-Ling
Cao, Hui-Hui
Zheng, Yuan-Ru
Lu, Zi-Bin
Yang, Hua-Yi
Ma, Jia-Mei
Chen, Yu-Yao
Huo, Chuying
Tian, Chunyang
Liu, Jun-Shan
Yu, Lin-Zhong
author_facet Xie, Pei
Yan, Li-Jun
Zhou, Hong-Ling
Cao, Hui-Hui
Zheng, Yuan-Ru
Lu, Zi-Bin
Yang, Hua-Yi
Ma, Jia-Mei
Chen, Yu-Yao
Huo, Chuying
Tian, Chunyang
Liu, Jun-Shan
Yu, Lin-Zhong
author_sort Xie, Pei
collection PubMed
description Background: Acute lung injury (ALI) is a serious inflammatory disease with clinical manifestations of hypoxemia and respiratory failure. Presently, there is no effective treatment of ALI. Although emodin from Rheum palmatum L. exerts anti-ALI properties, the underlying mechanisms have not been fully explored. Purpose: This study aimed to investigate the therapeutic effect and mechanism of emodin on LPS-induced ALI in mice. Methods: RAW264.7 cells and zebrafish larvae were stimulated by LPS to establish inflammatory models. The anti-inflammatory effect of emodin was assessed by ELISA, flow cytometric analysis, and survival analysis. In vitro mechanisms were explored by using Western blotting, luciferase assay, electrophoretic mobility shift assay (EMSA), and small interfering RNA (siRNA) approach. The acute lung injury model in mice was established by the intratracheal administration of LPS, and the underlying mechanisms were assessed by detecting changes in histopathological and inflammatory markers and Western blotting in lung tissues. Results: Emodin inhibited the inflammatory factor production and oxidative stress in RAW264.7 cells, and prolonged the survival of zebrafish larvae after LPS stimulation. Emodin suppressed the expression levels of phosphorylated JNK at Thr183/tyr182 and phosphorylated Nur77 at Ser351 and c-Jun, and increased the expression level of Nur77 in LPS-stimulated RAW264.7 cells, while these regulatory effects of emodin on Nur77/c-Jun were counteracted by JNK activators. The overexpression of JNK dampened the emodin-mediated increase in Nur77 luciferase activity and Nur77 expression. Moreover, the inhibitory effect of emodin on c-Jun can be attenuated by Nur77 siRNA. Furthermore, emodin alleviated LPS-induced ALI in mice through the regulation of the JNK/Nur77/c-Jun pathway. Conclusions: Emodin protects against LPS-induced ALI through regulation on JNK/Nur77/c-Jun signaling. Our results indicate the potential of emodin in the treatment of ALI.
format Online
Article
Text
id pubmed-8968870
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89688702022-04-01 Emodin Protects Against Lipopolysaccharide-Induced Acute Lung Injury via the JNK/Nur77/c-Jun Signaling Pathway Xie, Pei Yan, Li-Jun Zhou, Hong-Ling Cao, Hui-Hui Zheng, Yuan-Ru Lu, Zi-Bin Yang, Hua-Yi Ma, Jia-Mei Chen, Yu-Yao Huo, Chuying Tian, Chunyang Liu, Jun-Shan Yu, Lin-Zhong Front Pharmacol Pharmacology Background: Acute lung injury (ALI) is a serious inflammatory disease with clinical manifestations of hypoxemia and respiratory failure. Presently, there is no effective treatment of ALI. Although emodin from Rheum palmatum L. exerts anti-ALI properties, the underlying mechanisms have not been fully explored. Purpose: This study aimed to investigate the therapeutic effect and mechanism of emodin on LPS-induced ALI in mice. Methods: RAW264.7 cells and zebrafish larvae were stimulated by LPS to establish inflammatory models. The anti-inflammatory effect of emodin was assessed by ELISA, flow cytometric analysis, and survival analysis. In vitro mechanisms were explored by using Western blotting, luciferase assay, electrophoretic mobility shift assay (EMSA), and small interfering RNA (siRNA) approach. The acute lung injury model in mice was established by the intratracheal administration of LPS, and the underlying mechanisms were assessed by detecting changes in histopathological and inflammatory markers and Western blotting in lung tissues. Results: Emodin inhibited the inflammatory factor production and oxidative stress in RAW264.7 cells, and prolonged the survival of zebrafish larvae after LPS stimulation. Emodin suppressed the expression levels of phosphorylated JNK at Thr183/tyr182 and phosphorylated Nur77 at Ser351 and c-Jun, and increased the expression level of Nur77 in LPS-stimulated RAW264.7 cells, while these regulatory effects of emodin on Nur77/c-Jun were counteracted by JNK activators. The overexpression of JNK dampened the emodin-mediated increase in Nur77 luciferase activity and Nur77 expression. Moreover, the inhibitory effect of emodin on c-Jun can be attenuated by Nur77 siRNA. Furthermore, emodin alleviated LPS-induced ALI in mice through the regulation of the JNK/Nur77/c-Jun pathway. Conclusions: Emodin protects against LPS-induced ALI through regulation on JNK/Nur77/c-Jun signaling. Our results indicate the potential of emodin in the treatment of ALI. Frontiers Media S.A. 2022-03-17 /pmc/articles/PMC8968870/ /pubmed/35370650 http://dx.doi.org/10.3389/fphar.2022.717271 Text en Copyright © 2022 Xie, Yan, Zhou, Cao, Zheng, Lu, Yang, Ma, Chen, Huo, Tian, Liu and Yu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Xie, Pei
Yan, Li-Jun
Zhou, Hong-Ling
Cao, Hui-Hui
Zheng, Yuan-Ru
Lu, Zi-Bin
Yang, Hua-Yi
Ma, Jia-Mei
Chen, Yu-Yao
Huo, Chuying
Tian, Chunyang
Liu, Jun-Shan
Yu, Lin-Zhong
Emodin Protects Against Lipopolysaccharide-Induced Acute Lung Injury via the JNK/Nur77/c-Jun Signaling Pathway
title Emodin Protects Against Lipopolysaccharide-Induced Acute Lung Injury via the JNK/Nur77/c-Jun Signaling Pathway
title_full Emodin Protects Against Lipopolysaccharide-Induced Acute Lung Injury via the JNK/Nur77/c-Jun Signaling Pathway
title_fullStr Emodin Protects Against Lipopolysaccharide-Induced Acute Lung Injury via the JNK/Nur77/c-Jun Signaling Pathway
title_full_unstemmed Emodin Protects Against Lipopolysaccharide-Induced Acute Lung Injury via the JNK/Nur77/c-Jun Signaling Pathway
title_short Emodin Protects Against Lipopolysaccharide-Induced Acute Lung Injury via the JNK/Nur77/c-Jun Signaling Pathway
title_sort emodin protects against lipopolysaccharide-induced acute lung injury via the jnk/nur77/c-jun signaling pathway
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968870/
https://www.ncbi.nlm.nih.gov/pubmed/35370650
http://dx.doi.org/10.3389/fphar.2022.717271
work_keys_str_mv AT xiepei emodinprotectsagainstlipopolysaccharideinducedacutelunginjuryviathejnknur77cjunsignalingpathway
AT yanlijun emodinprotectsagainstlipopolysaccharideinducedacutelunginjuryviathejnknur77cjunsignalingpathway
AT zhouhongling emodinprotectsagainstlipopolysaccharideinducedacutelunginjuryviathejnknur77cjunsignalingpathway
AT caohuihui emodinprotectsagainstlipopolysaccharideinducedacutelunginjuryviathejnknur77cjunsignalingpathway
AT zhengyuanru emodinprotectsagainstlipopolysaccharideinducedacutelunginjuryviathejnknur77cjunsignalingpathway
AT luzibin emodinprotectsagainstlipopolysaccharideinducedacutelunginjuryviathejnknur77cjunsignalingpathway
AT yanghuayi emodinprotectsagainstlipopolysaccharideinducedacutelunginjuryviathejnknur77cjunsignalingpathway
AT majiamei emodinprotectsagainstlipopolysaccharideinducedacutelunginjuryviathejnknur77cjunsignalingpathway
AT chenyuyao emodinprotectsagainstlipopolysaccharideinducedacutelunginjuryviathejnknur77cjunsignalingpathway
AT huochuying emodinprotectsagainstlipopolysaccharideinducedacutelunginjuryviathejnknur77cjunsignalingpathway
AT tianchunyang emodinprotectsagainstlipopolysaccharideinducedacutelunginjuryviathejnknur77cjunsignalingpathway
AT liujunshan emodinprotectsagainstlipopolysaccharideinducedacutelunginjuryviathejnknur77cjunsignalingpathway
AT yulinzhong emodinprotectsagainstlipopolysaccharideinducedacutelunginjuryviathejnknur77cjunsignalingpathway